D. Roy

发表

Creatine transport and creatine kinase activity is required for CD8+ T cell immunity.

E. Ma, Russell G. Jones, B. Samborska, 2022, Cell reports.

Targeting tumor vasculature with an oncolytic virus.

H. Atkins, A. Fenster, D. Kirn, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice

S. Sad, D. Roy, J. Bell, 2017, Journal of immunotherapy.

Programmable insect cell carriers for systemic delivery of integrated cancer biotherapy.

H. Atkins, D. Roy, J. Bell, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment

J. Diallo, D. Roy, J. Bell, 2016, Breast Cancer Research.

Model-based rational design of an oncolytic virus with improved therapeutic potential

Mads Kærn, H. Atkins, J. Diallo, 2013, Nature Communications.

Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy.

M. Cronin, D. Roy, J. Bell, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity

J. Diallo, B. Nelson, D. Roy, 2016, Molecular therapy oncolytics.

Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy

J. Diallo, D. Roy, J. Bell, 2018, Science Translational Medicine.

Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis

E. Ma, Russell G. Jones, F. Tzelepis, 2018, Science Immunology.

MicroRNAs regulate the immunometabolic response to viral infection in the liver.

Rodney K. Lyn, K. Rayner, D. Tyrrell, 2015, Nature chemical biology.

Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy.

Russell G. Jones, L. Nguyen, P. Ohashi, 2019, Cancer research.

Activation of Peroxisome Proliferator-Activated Receptors a and d Synergizes with In ﬂ ammatory Signals to Enhance Adoptive Cell Therapy

Russell G. Jones, L. Nguyen, P. Ohashi, 2019 .

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination

D. Roy, J. Bell, B. Lichty, 2021, Nature Communications.

Experimental Glioma Forest Virus and Vaccinia Virus, in Neurotropic Oncolytic Viruses, Semliki Resistance to Two Heterologous

J. Diallo, A. Hemminki, M. Vähä-Koskela, 2014 .

Resistance to Two Heterologous Neurotropic Oncolytic Viruses, Semliki Forest Virus and Vaccinia Virus, in Experimental Glioma

J. Diallo, A. Hemminki, M. Vähä-Koskela, 2012, Journal of Virology.

Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer

D. Roy, J. Bell, S. Workenhe, 2019, Scientific Reports.

Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy

Takafumi N. Yamaguchi, P. Boutros, J. Diallo, 2022, Nature Communications.

Improving the Delivery and Replication of Oncolytic Viruses

D. Roy, 2016 .

MicroRNA-9 Fine-Tunes Dendritic Cell Function by Suppressing Negative Regulators in a Cell-Type-Specific Manner.

Russell G. Jones, C. Krawczyk, D. Roy, 2020, Cell reports.

Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation.

Ajit S. Divakaruni, E. Ma, Russell G. Jones, 2018, Cell metabolism.

Methotrexate elicits pro-respiratory and anti-growth effects by promoting AMPK signaling

E. Ma, Russell G. Jones, D. Roy, 2020, Scientific Reports.

Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming.

Maxim N. Artyomov, E. Ma, Russell G. Jones, 2020, Cell metabolism.

Cell carriers for oncolytic viruses: current challenges and future directions

D. Roy, J. Bell, 2013, Oncolytic virotherapy.

Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies

D. Roy, M. Bourgeois-Daigneault, A. Aitken, 2017, Biomedicines.

Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.

D. Roy, J. Bell, T. Falls, 2016, ILAR journal.

Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells.

Takla Griss, E. Ma, B. Faubert, 2019, Immunity.

Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production

B. Pulendran, N. Sonenberg, T. Alain, 2010, Proceedings of the National Academy of Sciences.

Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer

D. Roy, J. Bell, S. Workenhe, 2019, Scientific Reports.

A conserved miRNA-183 cluster regulates the innate antiviral response

D. Roy, R. Singaravelu, J. Pezacki, 2019, The Journal of Biological Chemistry.

Immunometabolism in the Tumor Microenvironment

E. Ma, Russell G. Jones, D. Roy, 2021 .

Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment

J. Diallo, D. Roy, J. Bell, 2016, Breast Cancer Research.

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

J. Diallo, D. Roy, J. Bell, 2011, Journal of visualized experiments : JoVE.

13C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8+ T cells

E. Ma, Russell G. Jones, C. Krawczyk, 2023, bioRxiv.

Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways

Esben B. Svenningsen, Markus M. Rinschen, J. Diallo, 2024, Nature communications.